患者对治疗抑郁症的数字健康解决方案的满意度:一个范围审查
Maria Werenberg Sigvardt1, Rebekka Friis Lindegaard1, Uffe Kock Wiil1
1SDU Health Informatics and Technology, The Maersk Mc-Kinney Moller Institute, University of Southern Denmark, Odense, Denmark.
Studies in health technology and informatics
|May 17, 2025
概括
数字健康干预措施有望改善患者对抑郁症管理的满意度. 需要更多的研究才能将这些数字健康解决方案完全整合到慢性疾病护理中.
科学领域:
- 数字健康数字健康
- 心理健康 心理健康
- 慢性疾病管理 慢性疾病管理
背景情况:
- 有效的自我护理策略对于患有慢性疾病的患者至关重要.
- 对抑郁症和坚持治疗的数字健康干预措施的证据是零碎的.
- 患者对数字健康治疗的满意度需要进一步调查.
研究的目的:
- 对抑郁症治疗的数字健康治疗进行范围审查.
- 专门研究患者对这些数字干预措施的满意度.
- 确定将数字健康纳入抑郁症治疗中的研究缺口.
主要方法:
- 在PubMed,Scopus和CINAHL进行系统的文献搜索.
- 包括到2024年发表的研究.
- 对9项选定的研究进行分析.
主要成果:
- 数字健康干预措施通常似乎提高了患者的满意度.
- 在大多数审查的研究中,患者满意度不是主要结果.
- 目前,有限的研究集中在患者对数字抑郁症治疗的满意度上.
结论:
- 数字健康干预措施为抑郁症护理中的患者满意度提供了潜在的好处.
- 进一步的研究对于优化数字健康解决方案的整合至关重要.
- 在未来的抑郁症数字健康研究中,需要加强对患者满意度的关注.
相关概念视频
Depressive Disorders: MDD and Dysthymia
29
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
29
Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Depressive Disorders: Etiology
26
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
26


